Calmare Therapeutics (CTTC) Short Interest Ratio & Short Volume

Short interest is the volume of Calmare Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 7,800 shares of CTTC short. Learn More on Calmare Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTTC shares currently have a short interest ratio of 4.0. Learn More on Calmare Therapeutics's short interest ratio.

Here is how the short interest of companies in the sector of "medical" compare to Calmare Therapeutics: CVR Medical Corp. (0.03%), Nyxoah S.A. (2.90%), QuantRx Biomedical Co. (0.01%), Stevanato Group S.p.A. (4.79%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Palo Alto Networks, Inc. ($4.77 billion), Charter Communications, Inc. ($4.21 billion), HP Inc. ($2.60 billion), Lucid Group, Inc. ($2.33 billion), GameStop Corp. ($2.13 billion), Rivian Automotive, Inc. ($2.10 billion), Wayfair Inc. ($1.96 billion), Carnival Co. & plc ($1.81 billion), Teladoc Health, Inc. ($1.66 billion), and Plug Power Inc. ($1.63 billion). View all of the most shorted stocks.

Short selling CTTC is an investing strategy that aims to generate trading profit from Calmare Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Calmare Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CTTC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CTTC, twice per month. The most recent reporting period available is April, 15 2022.